Other conditions decisions — 2011

The Veteran's claims for service connection for chronic neck pain, numbness and tingling of the bilateral lower extremities, and hallux limitus of the right great toe have all been denied.,No compensable rating has been assigned for any of the disabilities on appeal.

The Veteran's appeal is remanded for additional development, including obtaining medical records and a VA examination to assess his ability to work due to service-connected disabilities.

The Veteran's appeal is being remanded for additional development, including obtaining medical records and scheduling a VA examination to assess the current severity of his service-connected hand disabilities.

The Board denied the Veteran's claims for service connection and benefits under the provisions of 38 U.S.C.A. § 1151, finding no evidence to support a link between his eye disorder and exposure to herbicides or VA medical treatment.

The Board denied the claim of service connection for the cause of the Veteran's death, finding that new and material evidence had not been submitted to establish a link between the Veteran's gastric carcinoma and his military service.

The Veteran's claims for service connection for Sprengel's deformity and scoliosis have been granted.,Both conditions are found to be related to the Veteran's active duty service.

The Veteran's unauthorized medical expenses incurred from September 30, 2005 through October 1, 2005 are approved as the emergent nature of his condition continued until he was deemed stable and discharged to home on October 1, 2005.

The Board has determined that the appellant is not eligible for Dependents' Educational Assistance (DEA) benefits under Chapter 35, Title 38 of the United States Code due to her reaching the age of 26 prior to the effective date of the eligibility determination.

The Veteran's claimed conditions were not incurred or aggravated by service, and the claim is denied.

The Board has remanded the case for additional development, including obtaining the Veteran's complete personnel records from the U.S. Postal Service and scheduling an appropriate VA examination to determine the current nature and likely etiology of the Veteran's ulcer.

The Board denied the appellant's claim for one-time payment from the Filipino Veterans Equity Compensation Fund due to a lack of qualified service.

The Board has granted service connection for the cause of the Veteran's death, finding that his glioblastoma multiforme is related to his presumed exposure to herbicides in Vietnam.

The Board has remanded the case for additional development, including a new VA neurological examination to determine the nature and etiology of the appellant's current disability.

The appellant does not have recognized active military service for the purpose of obtaining a one-time payment from the Filipino Veterans Equity Compensation Fund.

The Veteran's spouse is denied legal entitlement to a one-time payment from the Filipino Veterans Equity Compensation Fund due to her husband having died prior to the enactment of the American Recovery and Reinvestment Act of 2009.

The Veteran developed ototoxicity and vestibulopathy as a result of VA treatment for bacteremia/septic arthritis in April 2004. The Board found that the proximate cause was VA's failure to monitor Gentamicin levels, resulting in the development of these conditions.

The Veteran's claim for service connection for hidradenitis suppurativa and Favre-Racouchot is being remanded due to the need for further development, including a VA examination.

The Board dismissed the appeal due to the death of the appellant.

The Board finds that the Veteran's current right eye disabilities, including strabismic amblyopia, high hyperopic astigmatic refractive error, retinopathy, and cataracts, are not related to his service. The evidence does not support a finding of service connection for these conditions.

The Veteran's service-connected chemical burns to the hands have been granted.,The Veteran's service-connected chemical burns to the feet are currently rated at 10%.